|
1.
|
Gupta S, Hawker GA, Laporte A, Croxford R
and Coyte PC: The economic burden of disabling hip and knee
osteoarthritis (OA) from the perspective of individuals living with
this condition. Rheumatology. 44:1531–1537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Yoshimura N, Oka H, Muraki S, et al:
Epidemiology of osteoarthritis in Japan. J Jpn Orthop Assoc (In
Japanese). 81:17–21. 2007.
|
|
3.
|
Budewalter JA, Stanish WD, Rosier RN,
Schenck RC Jr, Dennis DA and Coutts RD: The increasing need for
nonoperative treatment of patients with osteoarthritis. Clin
Orthop. 385:36–45. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Rashad S, Revell P, Hemmingway A, Low F,
Rainsford K and Walker F: Effect of non-steroidal anti-inflammatory
drugs on the course of osteoarthritis. Lancet. 2:519–522. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Clayton JJ: Nutraceuticals in the
management of osteoarthritis. Orthopedics. 30:624–629.
2007.PubMed/NCBI
|
|
6.
|
Verbruggen G: Chondroprotective drugs in
degenerative joint diseases. Rheumatology. 45:129–138. 2005.
View Article : Google Scholar
|
|
7.
|
Goldberg VM and Buckwalter JA: Hyaluronans
in the treatment of osteoarthritis of the knee: evidence for
disease-modifying activity. Osteoarthritis Cartilage. 13:216–224.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Petrella RT: Hyaluronic acid for the
treatment of knee osteoarthritis: long-term outcomes from a
naturalistic primary care experience. Am J Phys Med Rehabil.
84:278–283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Sun SF, Hsu CW, Hwang CW, Hsu PT, Wang JL,
Tsai SL, Chou YJ, Hsu YW, Huang CM and Wang YL: Hyaluronate
improves pain, physical function and balance in the geriatric,
osteoarthritic knee: a 6-month follow-up study using clinical
tests. Osteoarthritis Cartilage. 14:696–701. 2006. View Article : Google Scholar
|
|
10.
|
Hunter DJ and Hellio Le
Graverand-Gastineau M-P: How close are we to having
structure-modifying drugs available? Rheum Dis Clin N Am.
34:789–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Gossec L and Dougados M: Intra-articular
treatments in osteoarthritis: from the symptomatic to the structure
modifying. Ann Rheum Dis. 63:478–482. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Patti AM, Gabriele A, Vulcano A, Ramieri
MT and Della Rocca C: Effect of hyaluronic acid on human
chondrocytes cell lines from articular cartilage. Tissue Cell.
33:294–300. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Akmal M, Siingh A, Anand A, Kesani A,
Aslam N, Goodship A and Bentley G: The effects of hyaluronic acid
on articular chondrocytes. J Bone Joint Surg Br. 87:1143–1149.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Adams ME, Lussier AJ and Peyron JG: A
risk-benefit assessment of injections of hyaluronan and its
derivatives in the treatment of knee osteoarthritis. Drug Saf.
23:115–130. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Huang SL, Ling PX and Zhang TM: Oral
absorption of hyaluronic acid and phospholipids complexes in rats.
World J Gastroenterol. 13:945–949. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hatayama T, Nagano M, Yamaguchi N, Kumagai
S and Ohnuki K: The effect of a supplement on knee pain and
discomfort evaluated by visual analog scale (VAS): a randomized,
double-blind, placebo-controlled study (in Japanese). Kenkoshien.
10:13–17. 2008.
|
|
17.
|
Ravaud P, Giraudean B, Auleley GR, Drape
JL, Rousselin B, Paolozzi L, Chastang C and Dougados M: Variability
in knee radiographing: implication for definition of radiological
progression in medical knee osteoarthritis. Ann Rheum Dis.
57:624–629. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Vignon E, Garnero P, Delmas P, Avouac B,
Bettica P, Boers M, Ehrich E, MacKillop N, Rovati L, Serni U,
Spector T and Reginster JY: Recommendations for the registiation of
drugs used in the treatment of osteoarthritis: an update on
biochemical markers. Osteoarthritis Cartilage. 9:289–293. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Garnero P and Delmas PD: Biomarkers in
osteoarthritis. Nature Clin Pract Rheumatol. 3:346–356. 2007.
View Article : Google Scholar
|
|
20.
|
Poole AR, Ionescu M, Fitzcharles MA and
Billinghurst RC: The assessment of cartilage degradation in vivo:
development of an immunoassay for the measurement of in body fluids
of type II collagen cleared by collagenases. J Immunol Methods.
294:145–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Garnero P, Ayral X, Rousseau J-C,
Christgau S, Sandell LJ, Dougados M and Delmas P: Uncoupling of
type II collagen synthesis and degradation predicts progression of
joint damage in patients with knee osteoarthritis. Arthritis Rheum.
46:2613–2624. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Cahue S, Sharma L, Dunlop D, Ionescu M,
Song J, Lobanok T, King L and Poole AR: The ratio of type II
collagen breakdown to synthesis and its relationship with the
progression of knee osteoarthritis. Osteoarthritis Cartilage.
15:819–823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Sato T and Iwaso H: An effectiveness study
of hyaluronic acid [Hyabest® (J)] in the treatment of
osteoarthritis of the knee on patients in the United States. J New
Rem Clin. 58:249–256. 2009.
|
|
24.
|
Kalman DS, Heimer M, Valdeon A, Schwartz H
and Sheldon E: Effect of a natural extract of chicken combs with a
high content of hyaluronic acid (Hyal-Joint®) on pain
relief and quality of life in subjects with knee osteoarthritis: a
pilot randomized double-blind placebo-controlled trial. Nutrition
J. 7:32008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Fransen M, McConnell S and Bell M:
Exercise for osteoarthritis of the hip or knee. Cochrane Database
Syst Rev (CD 004286). 2003.
|
|
26.
|
Roos EM and Dahlberg L: Positive effects
of moderate exercise on glycosaminoglycan content in knee
cartilage: a four-month, randomized, controlled trial in patients
at risk of osteoarthritis. Arthritis Rheum. 52:3507–3514. 2005.
View Article : Google Scholar
|
|
27.
|
Christgau S, Henrotin Y, Tankó LB, Rovati
LC, Collette J, Bruyere O, Deroisy R and Reginster JY:
Osteoarthritic patients with high cartilage turnover show increased
responsiveness to the cartilage protecting effects of glucosamine
sulfate. Clin Exp Rheumatol. 22:36–42. 2004.
|
|
28.
|
Cibere J, Thorne A, Kopec JA, Singer J,
Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu
M, Poole AR and Esdaile JM: Glucosamine sulfate and cartilage type
II collagen degradation in patients with knee osteoarthritis. J
Rheumatol. 32:896–902. 2005.PubMed/NCBI
|
|
29.
|
Mazières B, Hucher M, Zaïm M and Garnero
P: Effect of chondroitin sulfate in symptomatic knee
osteoarthritis: a multicentre, randomised, double-blind,
placebo-controlled study. Ann Rheum Dis. 66:639–645.
2007.PubMed/NCBI
|
|
30.
|
Bay-Jensen AC, Andersen TL, Charni-Ben
Tabassi N, Kristensen PW, Kjaersgaard-Andersen P, Sandell L,
Garnero P and Delaissé JM: Biochemical markers of type II collagen
breakdown and synthesis are positioned at specific sites in human
osteoarthritic knee cartilage. Osteoarthritis Cartilage.
16:615–623. 2008. View Article : Google Scholar : PubMed/NCBI
|
